Top 10 Best Health Industries Research Services of 2026

KLAS Research collects input from healthcare leaders and operational users to assess real-world performance of health technology and services. Coverage commonly spans applications and service relationships that affect frontline workflows, including implementation experience, support quality, and outcomes tied to day-to-day use. The research delivery format favors decision-ready narratives and comparative views that can be used in internal market reviews.

A key tradeoff is that KLAS Research emphasizes cross-customer perceptions and comparative ratings rather than building a custom dataset from raw operational sources. It fits usage situations where procurement teams need third-party benchmarking and where product and partner teams need validated feedback to prioritize roadmap changes. It is less suited for teams that require bespoke statistical modeling from proprietary claims or clinical datasets.

PwC can run healthcare market intelligence studies that combine qualitative input from healthcare stakeholders with quantitative analysis needed for provider market analysis and payer market analysis. Delivery commonly includes structured research plans, interview and advisory engagement workflows, and end-to-end synthesis into decision-ready deliverables for leadership teams. Governance tends to be stronger than small research boutiques because PwC teams usually manage cross-functional workstreams and internal review gates across strategy and analytics.

A key tradeoff is that PwC engagement depth can be tied to consulting delivery style, which can reduce speed when buyers need rapid, self-serve iterations. PwC is a strong fit for usage situations where research must align with program planning and market access strategy, including competitive assessments across multiple stakeholder groups.

Deloitte works well for healthcare market intelligence that needs cross-domain integration between payer strategy, provider market analysis, and biopharma market research. Teams commonly produce research outputs that map stakeholder perspectives to market sizing and forecasting assumptions, including segmentation for uptake, access constraints, and adoption drivers. Delivery typically fits organizations that need healthcare stakeholder interviews, plus structured synthesis for treatment pathway analysis and standard-of-care assessment decisions. Comparable providers like Mathematica and RTI often skew toward academic-grade quant and policy modeling depth, while IQVIA may emphasize commercial datasets and field research operations.

A key tradeoff for Deloitte is that engagements skew toward consulting-style cadence and governance, which can slow iterative research cycles versus methods-driven labs that offer faster turnarounds for single hypotheses. Deloitte is a strong fit when a buyer needs multiple workstreams coordinated into one decision narrative, such as simultaneous payer and provider landscape work. Deloitte is less ideal when the primary requirement is rapid, narrow quantitative output with minimal stakeholder work.

For buyer evaluation, Deloitte competes most directly on integration breadth across stakeholders and the ability to convert qualitative research into actionable market access research themes.

Kantar serves health industries research with mixed-method work that combines branded survey programs and qualitative healthcare research support across markets. The service delivery is oriented around structured deliverables for provider market analysis and healthcare market intelligence, including segmentation outputs and decision-ready reporting packs.

Kantar also supports data-driven competitor and pipeline analysis using study design, fieldwork management, and analytics workflows that map to payer, provider, and biopharma stakeholder needs. Integration depth depends on engagement setup because the research outputs are typically packaged for downstream use rather than operating as a single unified analytics product.

ZS Associates runs health industries research programs that translate stakeholder input into market sizing, segmentation, and go-to-market recommendations. The firm is known for structured consulting workflows that combine primary research, competitive intelligence, and analytics to support provider and payer market decisions.

Its engagements often include blueprinting for care delivery and treatment pathways, alongside evidence synthesis for standards of care and unmet need. ZS Associates is distinct for driving research through tightly managed study plans and decision-grade outputs geared toward execution stakeholders.

Oliver Wyman is a consulting-led health industries research service provider used by sponsors needing clinician and stakeholder input tied to market access implications. Its core capabilities center on healthcare market intelligence, healthcare stakeholder interviews, and provider market analysis for regions, segments, and care settings.

Work products typically translate primary research and secondary evidence into competitive intelligence, treatment pathway analysis, and strategy-ready recommendations for payer and provider decision makers. Engagements usually focus on insight synthesis and decision support rather than building reusable analytics pipelines.

ECG Management Consultants delivers health industries research focused on provider market analysis and health technology market research for stakeholders that need evidence tied to commercial and care delivery decisions. The firm is structured around consulting-style workstreams that translate qualitative healthcare research inputs into actionable findings for organizations evaluating where to invest or partner.

ECG Management Consultants also supports payer market analysis and competitive intelligence needs through stakeholder interviews, industry benchmarking, and structured synthesis rather than self-serve dashboards. Engagement outputs are typically produced as packaged reports and decision materials designed for cross-functional review cycles.

IQVIA is a healthcare industries research service provider focused on healthcare market intelligence, combining primary research with large-scale analytical assets. Its deliverables commonly span provider market analysis and payer market analysis, plus biopharma and medical device market research that ties competitive context to forecasting.

Cross-functional work frequently includes health economics and outcomes research, real-world evidence from claims and EHR sources, and structured stakeholder research for care pathway and patient journey mapping. In buyer evaluations against Mathematica and RTI, IQVIA typically differentiates through scale of healthcare data assets and integration into recurring decision workflows for market access and commercial planning.

Ipsos executes health technology market research and healthcare market intelligence using study design, recruitment, interviewing, and analytics into structured deliverables.

The delivery model fits workflows that depend on patient and clinician engagement or payer and provider stakeholder interviewing rather than on self-serve analytics tooling.

Integration and automation show up mainly in project intake and reporting rather than in a developer-oriented API surface for automated provisioning.

L.E.K. Consulting is a health industries research partner for buyers needing provider market analysis and payer market analysis tied to strategy decisions. Delivery centers on senior consulting teams producing both qualitative healthcare research and quantitative healthcare research outputs with clear implications for market access and competitive positioning.

Common engagement shapes include competitive intelligence, pipeline analysis, and healthcare stakeholder interviews rather than self-serve analytics. Governance and continuity come from structured project leadership, with workstreams aligned to client decision timelines and internal review cycles.